Edenred SE (OTCMKTS:EDNMY – Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 100 shares, a drop of 95.5% from the January 15th total of 2,200 shares. Based on an average daily volume of 17,100 shares, the short-interest ratio is currently 0.0 days.
Edenred Price Performance
OTCMKTS EDNMY opened at $16.50 on Thursday. The firm has a 50 day simple moving average of $16.27 and a 200-day simple moving average of $17.53. Edenred has a one year low of $14.00 and a one year high of $30.75.
Wall Street Analyst Weigh In
Separately, Barclays lowered Edenred from a “strong-buy” rating to a “hold” rating in a research note on Sunday, January 26th.
Edenred Company Profile
Edenred SE provides digital platform for services and payments for companies, employees, and merchants worldwide. It offers employee benefit solutions, including Ticket Restaurant, a solution that allows employees to take time out for lunch at a partner merchant; Ticket Alimentación that allows users to pay for groceries in neighborhood stores and supermarkets; Ticket Regalo, a gift voucher; Ticket CESU, a human services solution; Ticket Plus Card, a solution that enables the purchase of staples, such as food and fuel; Ticket Welfare, which employees can use to pay for a range of services, such as access to sports facilities and solutions for their children’s educational needs; Ticket Guardería for companies without on-site daycare facilities; Childcare Vouchers; Ticket EcoCheque, a solutions that encourages purchase of environmentally friendly products; Ticket Kadeos Culture and Ticket Cultura that are solutions for cultural goods and services.
Read More
- Five stocks we like better than Edenred
- Insider Trading – What You Need to Know
- PayPal: Time to Strike With Shares Down Double Digits?
- Expert Stock Trading Psychology Tips
- Lattice Semiconductor’s Market Reset Is Over: The Rebound Begins
- How to Most Effectively Use the MarketBeat Earnings Screener
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
Receive News & Ratings for Edenred Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edenred and related companies with MarketBeat.com's FREE daily email newsletter.